Recent Articles

Appointment strengthens commercial leadership to expand adoption of healthcare outcomes platform among leading physician organizations and device manufacturers

Experts at the Regenerative Medicine Orthopaedic Summit emphasized standardizing PRP metrics, following FDA-compliant marketing practices, moving away from corticosteroid injections, and delivering personalized, comprehensive care. Physicians shared how they use real-world data through DataBiologics to validate outcomes, guide decisions, and build trust with patients.

DataBiologics has been selected as a spoke in ARPA-H’s Investor Catalyst Hub, joining a national network focused on accelerating innovative, scalable healthcare solutions.

DataBiologics is very excited to announce that we have been selected as a finalist in the 2024 Arizona Innovation Challenge! We're proud to stand alongside Arizona's most innovative companies.

Dr. Kelly Cunningham uses DataBiologics to validate his orthobiologic protocols with real-world outcomes. By benchmarking against national data, he shows faster pain relief, longer-lasting results, and fewer repeat treatments—helping position biologics as a reliable alternative to surgery and conventional injections.

Dr. Chris Miars ditched outdated tracking tools and now uses live dashboards to boost patient confidence and streamline decision-making.

Victory in Motion uses real-world data from DataBiologics to validate their non-surgical joint program. With 94% patient satisfaction at 6 months and stronger results than single treatments, the clinic shows that outcomes improve when protocols guide care.

Resident physicians at NYU Langone used real-world PRP outcomes from the DataBiologics registry to study how treatment timing impacts knee osteoarthritis. With rapid access to structured data, they built a retrospective study and presented their findings at a national sports medicine conference highlighting a new path for research in training.